NTRK CONNECT’s Key Publication Snapshot 2 is now available. How familiar are you with the range of testing approaches to identify patients with NTRK fusion cancer?read more
Key Publication Snapshot 1 – Larotrectinib and Entrectinib efficacy and safety profile in solid tumours
NTRK CONNECT’s Key Publication Snapshot 1 is now available. What do we know in 2020 about the two approved TRK inhibitors Larotrectinib and Entrectinib?read more
Molecular subtypes in paediatric and adult sarcomas, including CIC-DUX4, NTRK gene fusions and SDH-deficient GIST
NTRK CONNECT have partnered with SARCOMA CONNECT to describe a number of the molecular subtypes that exist in paediatric and adult sarcomas. This includes a spotlight on the potential indicators that may hint at the presence of NTRK gene fusions.read more
NTRK CONNECT identified NTRK Gene Fusions on the ESMO OncologyPro portal as a practical guide on how to test for NTRK gene fusions and treat with TRK inhibitors.read more
NTRK CONNECT has identified NTRK Gene Fusions on the ESMO OncologyPro portal as a practical guide on how to test for NTRK gene fusions and treat with TRK inhibitors.read more
Please submit your clinical topic for the next NTRK CONNECT newsletter here.